Muthiah (Mano) Manoharan, PhDSenior Vice President of Drug Discovery at Alnylam Pharmaceuticals, Inc.
Profile
Dr. Muthiah (Mano) Manoharan serves as a Senior Vice President and a Distinguished Research Scientist at Alnylam Pharmaceuticals, Cambridge, Massachusetts, USA. Dr. Manoharan joined Alnylam in 2003. He built the chemistry group at Alnylam and pioneered the discovery and development of RNA interference-based human therapeutics. Dr. Manoharan has had a distinguished career as a world-leading chemist in the areas of oligonucleotide chemical modifications, conjugation chemistry, and delivery platforms (lipid nanoparticles, polymer conjugates, and complex-forming strategies). He is an author of more than 200 publications (nearly 37,000 citations with an h-index of 85 and an i10-index of 329) and over 400 abstracts, as well as the inventor of over 225 issued U.S. patents.
Agenda Sessions
Keynote Introduction by Session Chair and KEYNOTE PRESENTATION with Live Q&A - Bringing RNAi Therapeutics to Patients Around the World
2:45pmView SessionKeynote Introduction by Session Chair and KEYNOTE PRESENTATION with Live Q&A - Discovery and Development of Semaglutide – The First Orally Available GLP-1 Peptide for Treatment of Type 2 Diabetes
10:15amView SessionKeynote Introduction by Session Chair and KEYNOTE PRESENTATION with Live Q&A - Oligonucleotide Therapeutics: Past, Present and Future
10:15amView SessionPanel Discussion Moderator and Panelists
3:45pmView SessionSESSION NAME: Targeted Delivery of Oligonucleotides - SESSION CHAIR & SPEAKERS BELOW
On DemandView SessionSESSION NAME: Targeted Delivery of Oligonucleotides - SESSION CHAIR & SPEAKERS BELOW
On DemandView Session